Focused Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-112
| Closed | -$108K | – | 203 |
|
2024
Q1 | $108K | Buy |
112
+101
| +918% | +$97K | 0.02% | 151 |
|
2023
Q4 | $9.44K | Sell |
11
-15
| -58% | -$12.9K | ﹤0.01% | 549 |
|
2023
Q3 | $21.2K | Sell |
26
-43
| -62% | -$35K | ﹤0.01% | 415 |
|
2023
Q2 | $49.6K | Hold |
69
| – | – | 0.01% | 304 |
|
2023
Q1 | $56.7K | Hold |
69
| – | – | 0.01% | 285 |
|
2022
Q4 | $49.8K | Hold |
69
| – | – | 0.01% | 306 |
|
2022
Q3 | $48K | Hold |
69
| – | – | 0.01% | 283 |
|
2022
Q2 | $41K | Buy |
69
+15
| +28% | +$8.91K | 0.01% | 305 |
|
2022
Q1 | $38K | Hold |
54
| – | – | 0.01% | 337 |
|
2021
Q4 | $34K | Hold |
54
| – | – | 0.01% | 408 |
|
2021
Q3 | $33K | Hold |
54
| – | – | 0.01% | 421 |
|
2021
Q2 | $30K | Hold |
54
| – | – | 0.01% | 446 |
|
2021
Q1 | $26K | Hold |
54
| – | – | ﹤0.01% | 450 |
|
2020
Q4 | $26K | Buy |
54
+45
| +500% | +$21.7K | 0.01% | 416 |
|
2020
Q3 | $5K | Sell |
9
-150
| -94% | -$83.3K | ﹤0.01% | 569 |
|
2020
Q2 | $99K | Buy |
159
+150
| +1,667% | +$93.4K | 0.02% | 228 |
|
2020
Q1 | $4K | Hold |
9
| – | – | ﹤0.01% | 530 |
|
2019
Q4 | $3K | Hold |
9
| – | – | ﹤0.01% | 601 |
|
2019
Q3 | $2K | Sell |
9
-120
| -93% | -$26.7K | ﹤0.01% | 617 |
|
2019
Q2 | $40K | Buy |
129
+120
| +1,333% | +$37.2K | 0.01% | 338 |
|
2019
Q1 | $4K | Hold |
9
| – | – | ﹤0.01% | 558 |
|
2018
Q4 | $3K | Sell |
9
-2,109
| -100% | -$703K | ﹤0.01% | 577 |
|
2018
Q3 | $856K | Sell |
2,118
-124
| -6% | -$50.1K | 0.29% | 61 |
|
2018
Q2 | $773K | Buy |
+2,242
| New | +$773K | 0.27% | 60 |
|
2016
Q4 | – | Sell |
-10
| Closed | -$4K | – | 726 |
|
2016
Q3 | $4K | Hold |
10
| – | – | ﹤0.01% | 556 |
|
2016
Q2 | $3K | Hold |
10
| – | – | ﹤0.01% | 569 |
|
2016
Q1 | $4K | Hold |
10
| – | – | ﹤0.01% | 509 |
|
2015
Q4 | $5K | Buy |
+10
| New | +$5K | ﹤0.01% | 508 |
|